$PURE SEC Filings

Filed On	Filing
20 Oct 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities This Securities Purchase Agreement (this “Agreement”) is dated as of October 15, 2026, among Pure Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its ...
15 Jun 2026	10-Q
15 Jun 2026	8-K: Results of Operations and Financial Condition
05 May 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
17 Mar 2026	10-Q
17 Mar 2026	8-K: Results of Operations and Financial Condition
20 Feb 2026	8-K: Submission of Matters to a Vote of Security Holders
30 Dec 2025	Proxy statement: annual meeting on February 17, 2026 say-on-pay vote
18 Dec 2025	PRE 14A
15 Dec 2025	10-Q
15 Dec 2025	8-K: Results of Operations and Financial Condition
28 Nov 2025	Form 3: Kitchell Jeffrey Scott, President, Corporate Secretary Holds 12,998 shares of Common Stock
19 Nov 2025	8-K: Departure/Election of Directors or Officers; Compensation
29 Oct 2025	10-K
29 Oct 2025	8-K: Results of Operations and Financial Condition
16 Jun 2025	10-Q
16 Jun 2025	8-K: Results of Operations and Financial Condition
17 Mar 2025	10-Q
17 Mar 2025	8-K: Results of Operations and Financial Condition
28 Jan 2025	8-K: Submission of Matters to a Vote of Security Holders

Comments